ATA269187A - Neue tricyclische lactame - Google Patents

Neue tricyclische lactame

Info

Publication number
ATA269187A
ATA269187A AT0269187A AT269187A ATA269187A AT A269187 A ATA269187 A AT A269187A AT 0269187 A AT0269187 A AT 0269187A AT 269187 A AT269187 A AT 269187A AT A269187 A ATA269187 A AT A269187A
Authority
AT
Austria
Prior art keywords
lactame
new tricyclic
tricyclic
new
tricyclic lactame
Prior art date
Application number
AT0269187A
Other languages
English (en)
Other versions
AT398425B (de
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA000539111A priority Critical patent/CA1337654C/en
Priority to ZA874107A priority patent/ZA874107B/xx
Priority to AU74022/87A priority patent/AU601433B2/en
Priority to AR87307816A priority patent/AR247213A1/es
Priority to EP87108410A priority patent/EP0249223B1/de
Priority to IE154787A priority patent/IE61476B1/en
Priority to KR1019870005908A priority patent/KR950014572B1/ko
Priority to ES87108410T priority patent/ES2044870T3/es
Priority to DK300487A priority patent/DK170840B1/da
Priority to JP62145419A priority patent/JP2542213B2/ja
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Priority to AT0269187A priority patent/AT398425B/de
Priority to US07/352,675 priority patent/US4973585A/en
Priority to GR930400057T priority patent/GR3006802T3/el
Publication of ATA269187A publication Critical patent/ATA269187A/de
Application granted granted Critical
Publication of AT398425B publication Critical patent/AT398425B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
AT0269187A 1986-06-13 1987-10-12 Neue tricyclische lactame AT398425B (de)

Priority Applications (13)

Application Number Priority Date Filing Date Title
CA000539111A CA1337654C (en) 1986-06-13 1987-06-08 Fused tricyclic lactams as antihypertensive agents
ZA874107A ZA874107B (de) 1986-06-13 1987-06-08
AU74022/87A AU601433B2 (en) 1986-06-13 1987-06-09 Novel antihypertensive agent
AR87307816A AR247213A1 (es) 1986-06-13 1987-06-09 Preparacion de acido 7-¡(1-carboxi-3-fenilpropil)amino¿-3,4,6,7,8,12b-octahidro-6-oxopirido ¡2,1-a¿ o hexahidro-6-oxo-1h(1,4-tiazino¡3,4-a¿¡2¿-benzazepin-4-carboxilico, agentes hipertensivos.
IE154787A IE61476B1 (en) 1986-06-13 1987-06-11 Novel antihypertensive agent
KR1019870005908A KR950014572B1 (ko) 1986-06-13 1987-06-11 융합된 트리사이클릭 락탐 및 이의 제조방법
EP87108410A EP0249223B1 (de) 1986-06-13 1987-06-11 Antihypertensives Mittel
ES87108410T ES2044870T3 (es) 1986-06-13 1987-06-11 Un procedimiento para la preparacion de nuevos agentes antihipertensivos.
DK300487A DK170840B1 (da) 1986-06-13 1987-06-12 Tricycliske lactamer indeholdende en benzazepingruppe, lægemiddel indeholdende sådanne lactamer samt anvendelse deraf til fremstilling af et lægemiddel til behandling af hypertension
JP62145419A JP2542213B2 (ja) 1986-06-13 1987-06-12 抗高血圧剤として有用な新規化合物とその製法
AT0269187A AT398425B (de) 1986-06-13 1987-10-12 Neue tricyclische lactame
US07/352,675 US4973585A (en) 1986-06-13 1989-05-10 Tricyclic lactams active as antihypertensive agents
GR930400057T GR3006802T3 (de) 1986-06-13 1993-01-14

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87375486A 1986-06-13 1986-06-13
AT0269187A AT398425B (de) 1986-06-13 1987-10-12 Neue tricyclische lactame

Publications (2)

Publication Number Publication Date
ATA269187A true ATA269187A (de) 1994-04-15
AT398425B AT398425B (de) 1994-12-27

Family

ID=25598925

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0269187A AT398425B (de) 1986-06-13 1987-10-12 Neue tricyclische lactame

Country Status (12)

Country Link
EP (1) EP0249223B1 (de)
JP (1) JP2542213B2 (de)
KR (1) KR950014572B1 (de)
AR (1) AR247213A1 (de)
AT (1) AT398425B (de)
AU (1) AU601433B2 (de)
CA (1) CA1337654C (de)
DK (1) DK170840B1 (de)
ES (1) ES2044870T3 (de)
GR (1) GR3006802T3 (de)
IE (1) IE61476B1 (de)
ZA (1) ZA874107B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
AU642321B2 (en) * 1990-12-21 1993-10-14 Merrell Pharmaceuticals Inc. Novel amino and nitro containing tricyclic compounds useful as inhibitors of ace
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
AU657793B2 (en) * 1991-09-27 1995-03-23 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
CA2078759C (en) * 1991-09-27 2003-09-16 Alan M. Warshawsky Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
EP0534363B1 (de) * 1991-09-27 1997-07-09 Merrell Pharmaceuticals Inc. 2-Substituierte Indan-2-Mercaptoacetylamid-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
WO1993016103A1 (en) * 1992-02-14 1993-08-19 Merrell Dow Pharmaceuticals Inc. Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
AU669364B2 (en) * 1992-05-15 1996-06-06 Merrell Pharmaceuticals Inc. Novel mercaptoacetylamido pyridazo(1,2)pyridazine, pyrazolo(1,2)pyridazine, pyridazo(1,2-a)(1,2)diazepine and pyrazolo(1,2-a)(1,2)diazepine derivatives useful as inhibitors of enkephalinase and ace
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
CA2146238C (en) * 1992-10-30 2001-03-13 Gary A. Flynn Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
US5654294A (en) * 1993-05-13 1997-08-05 Bristol-Myers Squibb Spiro lactam dual action inhibitors
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
KR100310592B1 (ko) * 1993-11-19 2002-05-13 메렐 파마슈티칼스 인크. (s)-1-(2(s)-(1,3-디히드로-1,3-디옥소-이소인도-2-일)-1-옥소-3-페닐프로필)-1,2,3,4-테트라히드로-2-피리딘-카르복실산메틸에스테르및그의중간체의신규제조방법
HUT74385A (en) * 1994-02-14 1996-12-30 Merrell Pharma Inc Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
HUT74584A (en) * 1994-02-14 1997-01-28 Merrell Pharma Inc Novel heterocycle fused benzazepine-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase, process for producing them and pharmaceutical compositions containing them
CN1142831A (zh) * 1994-02-14 1997-02-12 默里尔药物公司 用作脑啡肽酶和ace抑制剂的新的2-取代的1,2-二氢化茚-2-巯基乙酰胺二硫化物衍生物
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
ES2131806T3 (es) * 1994-02-14 1999-08-01 Merrell Pharma Inc Nuevos derivados de disulfuro de mercaptoacetilamida utiles como inhibidores de encefalinasa y ace.
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
HUT75160A (en) * 1994-03-24 1997-04-28 Merrell Pharma Inc Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives
CN1144482A (zh) * 1994-03-24 1997-03-05 默里尔药物公司 降低胆固醇、抗动脉粥样硬化和降低甘油三酯的巯基乙酰胺二硫化物衍生物
US5641880A (en) * 1994-12-21 1997-06-24 Hoechst Marion Roussel, Inc. Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
ATE266040T1 (de) * 1994-12-21 2004-05-15 Aventis Pharma Inc Verfahren zur herstellung von zwischenprodukten von inhibitoren von enkephalinase und angiotensin konvertierendem enzym und zwischenprodukte davon
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3373469D1 (en) * 1982-09-30 1987-10-15 Merck & Co Inc 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents
EP0166357A3 (de) * 1984-06-26 1988-10-26 Merck & Co. Inc. Kondensierte Benzo-Laktame und deren pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
GR3006802T3 (de) 1993-06-30
EP0249223B1 (de) 1992-10-14
KR880000399A (ko) 1988-03-25
AU601433B2 (en) 1990-09-13
JP2542213B2 (ja) 1996-10-09
DK170840B1 (da) 1996-02-05
CA1337654C (en) 1995-11-28
EP0249223A3 (en) 1989-01-25
JPS62298591A (ja) 1987-12-25
EP0249223A2 (de) 1987-12-16
IE871547L (en) 1987-12-13
AT398425B (de) 1994-12-27
AR247213A1 (es) 1994-11-30
DK300487D0 (da) 1987-06-12
DK300487A (da) 1987-12-14
ES2044870T3 (es) 1994-01-16
KR950014572B1 (ko) 1995-12-08
IE61476B1 (en) 1994-11-02
AU7402287A (en) 1987-12-17
ZA874107B (de) 1987-12-09

Similar Documents

Publication Publication Date Title
ATA269187A (de) Neue tricyclische lactame
DK624887A (da) Tricycliske ketoner
DK628087D0 (da) Diazepinderivater
PT85102A (de) Neue komplexverbindungen
DK662687D0 (da) Anvendelse af tricycliske carbazoloner
DK10087A (da) Praeparat
DK244488A (da) Efterskummende praeparat
DK255787D0 (da) Praeparat
DK477287D0 (da) Tricycliske forbindelser
DK290487A (da) Substituerede 3-amino-2-benzoylcyklohex-2-enoner
BR8703802A (pt) Conjunto seccionador
DK8188A (da) Veterinaert praeparat
IS3289A7 (is) Þríhringja ketónar
FR2604609B3 (fr) Bavoir
DK30788A (da) Co-vaccinationspraeparat
ATA103088A (de) Neue chinolinthioaether
BR8704164A (pt) Grupo pistao-biela de tipo aperfeicoado
ATA313787A (de) Neue prostacycline
KR880004244U (ko) 다색 배턴
DK355787D0 (da) Tricycliske forbindelser
KR880009302U (ko) 간이 의자의 골조
PT83101B (de) Neue cycloaliphatische ketoamine
BR8603397A (pt) Multicor
ATA313887A (de) Neue prostacycline
SE8600796D0 (sv) Sesambeslaget

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee